全文获取类型
收费全文 | 732篇 |
免费 | 337篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 5篇 |
妇产科学 | 1篇 |
基础医学 | 159篇 |
口腔科学 | 50篇 |
临床医学 | 62篇 |
内科学 | 114篇 |
皮肤病学 | 22篇 |
神经病学 | 47篇 |
特种医学 | 3篇 |
外科学 | 78篇 |
综合类 | 42篇 |
预防医学 | 7篇 |
眼科学 | 3篇 |
药学 | 102篇 |
中国医学 | 31篇 |
肿瘤学 | 350篇 |
出版年
2023年 | 5篇 |
2022年 | 9篇 |
2021年 | 29篇 |
2020年 | 136篇 |
2019年 | 117篇 |
2018年 | 108篇 |
2017年 | 107篇 |
2016年 | 95篇 |
2015年 | 97篇 |
2014年 | 109篇 |
2013年 | 73篇 |
2012年 | 61篇 |
2011年 | 47篇 |
2010年 | 25篇 |
2009年 | 10篇 |
2008年 | 5篇 |
2007年 | 6篇 |
2006年 | 4篇 |
2005年 | 3篇 |
2004年 | 3篇 |
2003年 | 5篇 |
2002年 | 6篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
排序方式: 共有1081条查询结果,搜索用时 15 毫秒
41.
Expression of tumor suppressive microRNA‐34a is associated with a reduced risk of bladder cancer recurrence 下载免费PDF全文
Angeline S. Andrew Carmen J. Marsit Alan R. Schned John D. Seigne Karl T. Kelsey Jason H. Moore Laurent Perreard Margaret R. Karagas Lorenzo F. Sempere 《International journal of cancer. Journal international du cancer》2015,137(5):1158-1166
Bladder cancer is the fourth most common cancer among men in the United States and more than half of patients experience recurrences within 5 years after initial diagnosis. Additional clinically informative and actionable biomarkers of the recurrent bladder cancer phenotypes are needed to improve screening and molecular therapeutic approaches for recurrence prevention. MicroRNA‐34a (miR‐34a) is a short noncoding regulatory RNA with tumor suppressive attributes. We leveraged our unique, large, population‐based prognostic study of bladder cancer in New Hampshire, United States to evaluate miR‐34a expression levels in individual tumor cells to assess prognostic value. We collected detailed exposure and medical history data, as well as tumor tissue specimens from bladder patients and followed them long‐term for recurrence, progression and survival. Fluorescence‐based in situ hybridization assays were performed on urothelial carcinoma tissue specimens (n = 229). A larger proportion of the nonmuscle invasive tumors had high levels of miR‐34a within the carcinoma cells compared to those tumors that were muscle invasive. Patients with high miR‐34a levels in their baseline nonmuscle invasive tumors experienced lower risks of recurrence (adjusted hazard ratio 0.57, 95% confidence interval 0.34–0.93). Consistent with these observations, we demonstrated a functional tumor suppressive role for miR‐34a in cultured urothelial cells, including reduced matrigel invasion and growth in soft agar. Our results highlight the need for further clinical studies of miR‐34a as a guide for recurrence screening and as a possible candidate therapeutic target in the bladder. 相似文献
42.
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway 下载免费PDF全文
Kei Mitsuhashi Hiroyoshi Kurihara Hisayoshi Igarashi Taiga Takahashi Mami Tachibana Hiroaki Takahashi Shinji Yoshii Toshinao Takenouchi Tadashi Hasegawa Kenji Okita Koichi Hirata Reo Maruyama Hiromu Suzuki Kohzoh Imai Yasuhisa Shinomura 《International journal of cancer. Journal international du cancer》2015,137(6):1258-1268
Human gut microbiota is being increasingly recognized as a player in colorectal cancers (CRCs). Evidence suggests that Fusobacterium nucleatum (F. nucleatum) may contribute to disease progression and is associated with CpG island methylator phenotype (CIMP) and microsatellite instability (MSI) in CRCs; however, to date, there are no reports about the relationship between F. nucleatum and molecular features in the early stage of colorectal tumorigenesis. Therefore, we investigated the presence of F. nucleatum in premalignant colorectal lesions. In total, 465 premalignant lesions (343 serrated lesions and 122 non‐serrated adenomas) and 511 CRCs were studied. We determined the presence of F. nucleatum and analyzed its association with molecular features including CIMP, MSI and microRNA‐31 status. F. nucleatum was detected in 24% of hyperplastic polyps, 35% of sessile serrated adenomas (SSAs), 30% of traditional serrated adenomas (TSAs) and 33% of non‐serrated adenomas. F. nucleatum was more frequently detected in CIMP‐high premalignant lesions than in CIMP‐low/zero lesions (p = 0.0023). In SSAs, F. nucleatum positivity increased gradually from sigmoid colon to cecum (p = 0.042). F. nucleatum positivity was significantly higher in CRCs (56%) than in premalignant lesions of any histological type (p < 0.0001). In conclusion, F. nucleatum was identified in premalignant colorectal lesions regardless of histopathology but was more frequently associated with CIMP‐high lesions. Moreover, F. nucleatum positivity increased according to histological grade, suggesting that it may contribute to the progression of colorectal neoplasia. Our data also indicate that F. nucleatum positivity in SSAs may support the “colorectal continuum” concept. 相似文献
43.
Epstein‐Barr virus infection induces miR‐21 in terminally differentiated malignant B cells 下载免费PDF全文
Eleni Anastasiadou Neha Garg Rachele Bigi Shivangi Yadav Antonio Francesco Campese Caterina Lapenta Massimo Spada Laura Cuomo Annalisa Botta Filippo Belardelli Luigi Frati Elisabetta Ferretti Pankaj Trivedi 《International journal of cancer. Journal international du cancer》2015,137(6):1491-1497
The association of Epstein‐Barr virus (EBV) with plasmacytoid malignancies is now well established but how the virus influences microRNA expression in such cells is not known. We have used multiple myeloma (MM) cell lines to address this issue and find that an oncomiR, miR‐21 is induced after in vitro EBV infection. The PU.1 binding site in miR‐21 promoter was essential for its activation by the virus. In accordance with its noted oncogenic functions, miR‐21 induction in EBV infected MM cells caused downregulation of p21 and an increase in cyclin D3 expression. EBV infected MM cells were highly tumorigenic in SCID mice. Given the importance of miR‐21 in plasmacytoid malignancies, our findings that EBV could further exacerbate the disease by inducing miR‐21 has interesting implications both in terms of diagnosis and future miR based therapeutical approaches for the virus associated plasmacytoid tumors. 相似文献
44.
Kristina Althoff Sven Lindner Andrea Odersky Pieter Mestdagh Anneleen Beckers Sarah Karczewski Jan J. Molenaar Anna Bohrer Shirley Knauer Frank Speleman Matthias Epple Diana Kozlova Sena Yoon Kwanghee Baek Jo Vandesompele Angelika Eggert Alexander Schramm Johannes H. Schulte 《International journal of cancer. Journal international du cancer》2015,136(6):1308-1320
45.
K14‐EGFP‐miR‐31 transgenic mice have high susceptibility to chemical‐induced squamous cell tumorigenesis that is associating with Ku80 repression 下载免费PDF全文
Ssu‐Hsueh Tseng Cheng‐Chieh Yang En‐Hao Yu Christine Chang Yong‐Syu Lee Chung‐Ji Liu Kuo‐Wei Chang Shu‐Chun Lin 《International journal of cancer. Journal international du cancer》2015,136(6):1263-1275
Squamous cell carcinoma (SCC) occurring in the head and neck region and the esophagus causes tremendous cancer mortality around the world. miR‐31 is among the most eminently upregulated MicroRNAs in SCC, when it occurs in the head and neck region and the esophagus. We established miR‐31 transgenic mouse lines, in which miR‐31 is under the control of the K14 promoter. 4‐nitroquinoline 1‐oxide (4NQO) is a mutagen that causes double strand breaks. The transgenic mice exhibited a higher potential for tumor induction than wild‐type (Wt) mice of the tongue and esophagus after 4NQO treatment. After 4NQO treatment or irradiation, p‐γH2AX expression in squamous epithelium of transgenic mice was increased more than in Wt mice. Exogenous expression of miR‐31 was also found to be associated with the higher p‐γH2AX expression induced by 4NQO in human oral SCC (OSCC) cell lines. The repair genes PARP1 and Ku80 were validated as new targets of miR‐31 in human OSCC cell lines, and were found to be downregulated in the squamous epithelium of the tongue in transgenic mice. However, only the downregulation of Ku80 was essential for maintaining the high level of p‐γH2AX induced by 4NQO in OSCC cells. Inverse expression profiles for miR‐31 and Ku80 were noted in human OSCC tissue. Our study identifies the high sensitivity of K14‐EGFP‐miR‐31 transgenic mice to chemical carcinogen‐induced squamous cell tumorigenesis and shows that this seems to be associated with the downregulation of Ku80 and an impairment of repair activity in squamous cells, which are mediated by miR‐31. 相似文献
46.
Hong Xie Linkiat Lee Patrick Scicluna Ersen Kavak Catharina Larsson Rickard Sandberg Weng‐Onn Lui 《International journal of cancer. Journal international du cancer》2015,136(5):E230-E241
Altered expression of specific microRNAs (miRNAs) has been observed in human cervical cancer. However, the biological functions of many of these miRNAs are yet to be discovered. We previously showed that miR‐944 is significantly more abundant in cervical cancer tissues than their normal counterparts. In this study, we investigated the functions and targets of miR‐944 in human cervical cancer cells. MiR‐944 is located in the intron of the tumor protein p63 (TP63) gene, which is frequently overexpressed in cervical carcinomas. Using gain‐ and loss‐of‐function experiments in vitro, we demonstrate that miR‐944 promotes cell proliferation, migration and invasion, but has no effect on apoptosis, in human cervical cancer cells. To identify the targets of miR‐944, we performed photoactivatable‐ribonucleoside‐enhanced crosslinking and immunoprecipitation followed by deep sequencing. Among the candidate targets, we validated HECW2 (HECT domain ligase W2) and S100PBP (S100P binding protein) as direct targets of miR‐944 using luciferase reporter assays and western blot analysis. Our findings reveal novel functions and targets of miR‐944 in human cervical cancer cells, which may provide new insights of its role in cervical carcinogenesis. 相似文献
47.
Theresa Thor Annette Künkele Kristian W. Pajtler Annika K. Wefers Harald Stephan Pieter Mestdagh Lukas Heukamp Wolfgang Hartmann Jo Vandesompele Natalie Sadowski Lore Becker Lillian Garrett Sabine M. Hölter Marion Horsch Julia Calzada‐Wack Tanja Klein‐Rodewald Ildiko Racz Andreas Zimmer Johannes Beckers Frauke Neff Thomas Klopstock Pasqualino De Antonellis Massimo Zollo Wolfgang Wurst Helmut Fuchs Valérie Gailus‐Durner Ulrich Schüller Martin Hrabě de Angelis Angelika Eggert Johannes H. Schulte 《International journal of cancer. Journal international du cancer》2015,136(10):2293-2303
Previous studies have evaluated the role of miRNAs in cancer initiation and progression. MiR‐34a was found to be downregulated in several tumors, including medulloblastomas. Here we employed targeted transgenesis to analyze the function of miR‐34a in vivo. We generated mice with a constitutive deletion of the miR‐34a gene. These mice were devoid of mir‐34a expression in all analyzed tissues, but were viable and fertile. A comprehensive standardized phenotypic analysis including more than 300 single parameters revealed no apparent phenotype. Analysis of miR‐34a expression in human medulloblastomas and medulloblastoma cell lines revealed significantly lower levels than in normal human cerebellum. Re‐expression of miR‐34a in human medulloblastoma cells reduced cell viability and proliferation, induced apoptosis and downregulated the miR‐34a target genes, MYCN and SIRT1. Activation of the Shh pathway by targeting SmoA1 transgene overexpression causes medulloblastoma in mice, which is dependent on the presence and upregulation of Mycn. Analysis of miR‐34a in medulloblastomas derived from ND2:SmoA1(tg) mice revealed significant suppression of miR‐34a compared to normal cerebellum. Tumor incidence was significantly increased and tumor formation was significantly accelerated in mice transgenic for SmoA1 and lacking miR‐34a. Interestingly, Mycn and Sirt1 were strongly expressed in medulloblastomas derived from these mice. We here demonstrate that miR‐34a is dispensable for normal development, but that its loss accelerates medulloblastomagenesis. Strategies aiming to re‐express miR‐34a in tumors could, therefore, represent an efficient therapeutic option. 相似文献
48.
Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing 下载免费PDF全文
49.
Xiaoying Wang Fengshu Zhao Xiangfeng He Jing Wang Ying Zhang Hongyi Zhang Yaoyao Ni Jianan Sun Xiaobing Wang Jun Dou 《Oncotarget》2015,6(14):12493-12504
TGF-β1 secreted abundantly by tumors cells as well as present in the local microenvironment promotes neoplasm invasion and metastasis by triggering the epithelial to mesenchymal transition (EMT). MiR200c has been shown to suppress EMT and to regulate the cellular epithelial and interstitial state conversion, whereas the tumor vaccines are intended to specifically initiate or amplify a host response against evolving tumor cells. Our study aimed at optimizing the antitumor effects of the B16F10/glycosylphosphatidylinositol-interleukin 21 (B16F10/GPI-IL-21) tumor vaccine on melanoma bearing mice by combining the TGF-β1 knockdown and the administration of miR200c agomir. The mice were subcutaneously vaccinated with inactivated B16F10/GPI-IL-21 vaccine and challenged by B16F10 cells transfected with shTGF-β1 (B16F10/shTGF-β1 cells) or B16F10/shTGF-β1 cells with the administration of miR200c agomir. The later combination showed that, when compared with the mice in the control group that received no vaccination, vaccinated mice significantly increased NK and CTL activities, enhanced levels of IFN-γ, and reduced expression of TGF-β1, N-cadherin, Vimentin, Gli1/2, P-Smad2/3 and others involved in promoting expression of EMT-related molecules in tumor areas, and inhibited the melanoma metastasis in lungs and lymph nodes. Altogether, our findings demonstrate that this synergistic anti-cancer regimen effectively induces strong immune response and diminishes the melanoma progression. 相似文献
50.
Xiaorong Lin Lijun Chen Yandang Yao Ruihua Zhao Xiuying Cui Jun Chen Kailian Hou Mingxia Zhang Fengxi Su Jingqi Chen Erwei Song 《Oncotarget》2015,6(24):20485-20499
Our previous work has indicated that CCL18 secreted by tumor-associated macrophages (TAMs) promotes breast cancer metastasis, which is associated with poor patient prognosis. However, it remains unclear whether microRNAs (miRNAs), which may modulate multiple cellular pathways, are involved in the regulation of CCL18 signaling and the ensuing metastasis of breast cancer. In this study, we demonstrated that CCL18 reduces miR98 and miR27b expression via the N-Ras/ERK/PI3K/NFκB/Lin28b signaling pathway, while down-regulation of these mRNAs feedbacks to increase N-Ras and Lin28b levels. This cascade of events forms a positive feedback loop that sustains the activation of CCL18 signaling. More importantly, reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition (EMT) of breast cancer cells, and thus promotes breast cancer metastasis. These findings suggest that down-regulation of miR98 and miR27b promotes CCL18-mediated invasion and migration of breast cancer cells. 相似文献